Carna Health
- Company typePrivate
- Founded2023
- HeadquartersBoston, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
Carna Health firmographics
Firmographics- Name
- Carna Health
- Legal name
- Carna Inc.
- Website
- https://carna.health
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Carna Health industry classification
Industry- Product category
- Digital Health Platform
- NAICS
- Medical and Diagnostic Laboratories (62151), Computer Systems Design and Related Services (54151)
- SIC
- Services-Prepackaged Software (7372), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)
- akta.pro secondary industry
- EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps (HLACAAAN)
Keywords
Where Carna Health is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Carna Health business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Platform/SaaS Licensing: Enterprise licensing of the Carna CKM Intelligence Platform to health systems, governments, and healthcare organizations for population health management and CKD screening programs.
- Professional Services: Implementation support, training, and program deployment services for health systems and government health ministries adopting the platform.
Distribution channels4 records
Marketing channels9 records
Carna Health product offering
Product offeringCore offering
Carna Health develops an AI-driven, cloud-based platform (the Carna CKM Intelligence Platform) that combines FDA-cleared point-of-care testing devices with predictive analytics for early detection, management, and prevention of Cardio-Kidney-Metabolic (CKM) syndrome at population scale. The platform is delivered to health systems and government health ministries through three surfaces: an enterprise intelligence platform, a clinician-facing Carna Provider App, and a Carna Patient App, supported by FHIR/HL7 interoperability with EHRs, labs, HIEs, and wearables.
Product overview
Carna Health offers the Carna Suite, a unified CKM CARE AI-POWERED PLATFORM consisting of three interconnected products designed to detect, manage, and prevent Cardio-Kidney-Metabolic (CKM) syndrome at population scale. The core product is the Carna CKM Intelligence Platform - an AI-powered, cloud-based enterprise system that aggregates data from multiple sources via omnichannel ingestion (POCT devices, EHRs, HIEs, lab systems, wearables) to provide predictive analytics, patient risk scoring, and population health management. The Carna Provider App serves as the clinician-facing mobile interface with full patient panel access, medical records, AI clinical decision support, and care plan management with EHR synchronization. The Carna Patient App delivers the patient-facing experience with personalized CKM risk dashboards, health metric tracking, medication reminders, and culturally adapted educational content. Together, these three products form an end-to-end CKM screening platform combining FDA-cleared point-of-care devices with AI that identifies disease progression risk and routes patients to appropriate care pathways.
Differentiator
Problem solved
Functional benefit
Products and services
- Carna CKM Intelligence Platform AI-powered, cloud-based enterprise platform that ingests data from any device, lab, or EHR via FHIR/HL7 to identify CKM risk, predict disease progression, and deliver specialist-grade guidance to frontline providers at population scale. Targeted at health systems, hospitals, government health ministries, and healthcare provider organizations.
- Carna Provider App Clinician-facing mobile application providing secure, on-the-go access to patient panels with full medical histories, CKM risk profiles, real-time measurement data, AI clinical decision support, and EHR sync capabilities. Designed for nurses, pharmacists, primary care providers, and physicians managing CKM patients.
- Carna Patient App Patient-centered mobile application empowering individuals to understand their CKM risk, monitor health metrics, and stay connected with their care team through personalized risk dashboards, health data tracking, medication and appointment reminders, and culturally adapted educational content localized by region, language, and literacy level.
Quantifiable outcome
- Nearly 50% of screened community in Bermuda identified with previously undiagnosed CKD
- +3 more outcomes
Companies that use Carna Health
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles2 records
Carna Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
AI capability6 records
Feature9 records
Carna Health partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core, strategic and minor.
- RenalytixcoreLandmark partnership integrating Renalytix's FDA-approved KidneyIntelX.dkd diagnostic test with Carna Health's AI-driven digital health platform. Aims to help US health systems identify at-risk patients earlier through risk-guided interventions, reducing catastrophic 'crash' dialysis starts. Carna projects to screen 1 to 1.5 million additional lives globally by year-end through this collaboration. Addresses $130 billion annual Medicare spending on CKD.
- DiME (Digital Medicine Society)strategicFounding member of 'Scaling Trusted, High-Impact AI Care Navigation' initiative convening over 15 founding members including Intel (Title Sponsor), Google for Health, Boston Children's Hospital, Mass General Brigham, Stanford Medicine, and patient advocacy groups. Develops evidence-based standards and frameworks for responsible AI adoption in patient care navigation, aligned with CMS and ONC policy guidance.
- Siemens HealthineerscoreStrategic partnership to promote adoption of Carna's AI-enabled CKD platform and expand point-of-care testing systems in emerging markets. Involves integrating diagnostics infrastructure and launching large-scale CKD screening programs. Exclusive POC device integration enables eGFR & uACR results in under 15 minutes without lab requirements. Aims to enroll 25 million people worldwide by 2030. Covers 70+ countries.
- CESminorCES Global Stage for Next-Gen Tech Innovation provides platform for Carna Health to showcase its AI-powered CKD screening technology to a global technology audience.
Scale indicators12 records
Recent moves7 records
Expansion highlights6 records
Carna Health competitors and assessment
Company assessmentDirect peers
- Omada Health: Omada Health is a digital chronic-disease management platform focused on diabetes, hypertension, and obesity with employer and health-plan distribution. Carna shares the cardiometabolic/diabetes focus, AI-guided care pathways, and at-scale chronic-disease thesis, though Carna is upstream in detection/screening.
- Health Catalyst: Health Catalyst is a healthcare data and analytics enterprise platform serving health systems with population-health management, risk stratification, and quality-improvement tools. It competes for the same enterprise budget and operates at the intersection of AI, data, and clinical workflows that defines Carna's offering.
- Color Health: Color Health operates a population-scale health screening and risk-assessment platform combining POCT, AI, and clinical services for employers, health systems, and government programs. Strong analog to Carna's POCT-plus-AI screening model, with similar enterprise and government GTM.
- Biofourmis: Biofourmis is an AI-driven RPM and care-management platform focused on chronic conditions including heart failure and CKD, with hospital-at-home deployments. Directly comparable on AI + wearable/biometric ingestion + clinical decision support for chronic disease.
- Virta Health: Virta Health is a digital health company that combines continuous remote monitoring, AI-driven coaching, and clinician oversight to reverse type 2 diabetes and other cardiometabolic conditions. Highly comparable business model: digital platform + RPM + AI + specialty clinical guidance, with payer and employer distribution.
- DarioHealth: DarioHealth is a digital chronic-condition management platform spanning diabetes, hypertension, and musculoskeletal conditions, sold to employers, payers, and providers. Comparable chronic-disease digital therapeutics model with AI-driven personalization and remote monitoring.
- Renalytix: Renalytix develops FDA-approved KidneyIntelX.dkd, a blood-based prognostic diagnostic for diabetic kidney disease. Carna has a partnership with Renalytix but both target the same enterprise buyers (US health systems) and kidney-disease use case, making Renalytix the most directly comparable peer.
- Wellframe: Wellframe is a digital care management platform used by health plans and providers to deliver chronic-disease and behavioral-health support with omnichannel data ingestion. Similar health-plan/health-system enterprise GTM and chronic-condition focus as Carna.
Broad incumbents
- Siemens Healthineers: Siemens Healthineers is a global medical technology and diagnostics incumbent and Carna's exclusive POC device partner. While much larger and broader, Siemens operates the diagnostic device infrastructure (atellica, epoc) that Carna integrates with, and represents both a critical distribution channel and a potential competitive threat.
- Verily (Alphabet): Verily is Alphabet's health-tech arm building AI-driven population health, clinical research, and chronic-disease platforms. Comparable at the intersection of AI, longitudinal patient data, and chronic-disease management, though broader in scope and backed by significantly more capital.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Carna Health compliance and trust
Trust signalCompliance5 records
Carna Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Carna Health leadership team
Management profileNumber of profiles
Profiles11 records
Carna Health funding detail
Funding detailFunding overview
Funding rounds2 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Carna Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Carna Health
What does Carna Health do?
Carna Health develops an AI-driven, cloud-based platform (the Carna CKM Intelligence Platform) that combines FDA-cleared point-of-care testing devices with predictive analytics for early detection, management, and prevention of Cardio-Kidney-Metabolic (CKM) syndrome at population scale. The platform is delivered to health systems and government health ministries through three surfaces: an enterprise intelligence platform, a clinician-facing Carna Provider App, and a Carna Patient App, supported by FHIR/HL7 interoperability with EHRs, labs, HIEs, and wearables.
Is Carna Health a public or private company?
Carna Health is a private company. It is classified as venture growth investor backed and is currently operating.
When was Carna Health founded?
Carna Health was founded in 2023. It employs 11 to 50 people.
Where is Carna Health based?
Carna Health is headquartered in Boston, United States, in the North America region.
How does Carna Health make money?
Two revenue lines are on record. Platform/SaaS Licensing is the primary driver. The others are professional Services.
Who are Carna Health's main competitors?
Direct peers on record are Omada Health, Health Catalyst, Color Health, Biofourmis, Virta Health, DarioHealth, Renalytix and Wellframe. Broad incumbents are Siemens Healthineers and Verily (Alphabet).
Does Carna Health have an API?
No public API is recorded for Carna Health.
What industry is Carna Health in?
Carna Health's product category is Digital Health Platform. Its primary akta.pro industry code is HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity), with a secondary code of HLACAAAN, EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps. Its NAICS code is 62151 and its SIC code is 7372.